Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
317.50    0.50 (0.16%)
Bid:
315.50
Ask:
317.00
Spread: 1.50 (0.475%)
Market Cap: £732.37m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Acquisition

23 Dec 2024 07:00

RNS Number : 0182R
Chesnara PLC
23 December 2024
Β 

Β 

Β 

LEI Number: 213800VFRMBRTSZ3SJ06

Β 

Β 

23 December 2024

Β 

CHESNARA plc

("Chesnara" or "the Company")

Β 

ANNOUNCEMENT OF A SECOND PORTFOLIO ACQUISITION FROM CANADA LIFE UK

Β 

Chesnara plc, the European life and pensions consolidator, today announces it has reached an agreement with Canada Life Limited ("Canada Life UK") to acquire a closed portfolio of unit linked bonds and legacy pension business with approximately 17,000 policies and total assets under management of Β£1.5 billion as at 31 December 2023. As a result of the acquisition, the policies are expected to transfer to Chesnara's UK subsidiary, Countrywide Assured plc ("Countrywide Assured") at the end of 2025 (subject to the completion of a court-approved Part VII transfer). This transaction follows the previous acquisition of an individual onshore protection business from Canada Life in 2023.

Β 

In the interim period, Canada Life UK will reinsure the portfolio to Countrywide Assured, effective from 31 December 2023. The consideration as part of the reinsurance agreement is Β£2 million, funded from internal Group resources, and we expect the transaction to provide an uplift in the Group's Economic Value of at least Β£8 million, contribute Β£8 million of cash generation over a five year period, with a small initial reduction to the Group's Solvency II ratio of approximately 2 percentage points.

Β 

Steve Murray, Group Chief Executive, commented:

Β 

"We are pleased to continue our relationship with Canada Life through the agreement of our second recent transaction, following the acquisition of 47,000 protection policies that we announced last year. I am looking forward to welcoming these new customers and their advisors to Chesnara and they can be confident we will continue to provide high levels of customer service as part of a financially strong and growing group.

Β 

"This transaction, the sixth deal implemented in the past three years, will add additional scale to our UK business which now looks after over 300,000 policies, and provides an attractive return on investment for our shareholders. We continue to see a range of M&A opportunities and are highly confident in our ability to finance and execute such transactions on attractive terms for vendors, customers and our shareholders."

Β 

Β 

For further information, please contact:

Β 

Investor Enquiries

Sam Perowne

Head of Strategic Development & Investor Relations

Chesnara plc

E - sam.perowne@chesnara.co.uk

Β 

Media Enquiries

Roddy Watt

Director, Capital Markets

FWD

T - 020 7280 0651Β / 07714 770 493Β 

E - roddy.watt@fwdconsulting.co.uk

Β 

Notes to Editors

Chesnara (CSN.L) is a European life and pensions consolidator listed on the London Stock Exchange. It administers over one million policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands and as Movestic in Sweden.

Β 

Following a three-pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in Sweden, the Netherlands and the UK and by undertaking value-adding acquisitions of either companies or portfolios.

Β 

Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 20 years in succession.

Β 

Further details are available on the Company's website (www.chesnara.co.uk).

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
ACQFEWESSELSEIE
Date   Source Headline
23rd Nov 20177:30 amRNSHolding(s) in Company
23rd Nov 20177:00 amRNSResult of External Audit Tender
7th Nov 20177:00 amRNSDirector/PDMR Shareholding
1st Nov 20174:06 pmRNSTotal Voting Rights
7th Sep 20177:34 amRNSStatement re: the Legacy Review
31st Aug 20177:00 amRNSHalf-year Report
17th Aug 20174:00 pmRNSHolding(s) in Company
8th Aug 20177:00 amRNSNotice of Results
2nd Aug 20177:00 amRNSTotal Voting Rights
18th May 20177:00 amRNSResult of AGM
28th Apr 20173:26 pmRNSDirector/PDMR Shareholding
18th Apr 20177:00 amRNSAnnual Financial Report & AGM Notice
11th Apr 20172:06 pmRNSSCILDON - new name for Legal & General Nederland
6th Apr 20177:00 amRNSCompletion of LGN acquisition
31st Mar 20177:00 amRNSFinal Results
30th Mar 20175:15 pmRNSAcquisition
6th Mar 201712:11 pmRNSNotice of Results
6th Jan 20177:00 amRNSHolding(s) in Company
19th Dec 20167:00 amRNSHolding(s) in Company
16th Dec 20164:56 pmRNSUpdate on Excess Applications
16th Dec 20162:15 pmRNSHolding(s) in Company
15th Dec 20168:00 amRNSAdmission of Shares
14th Dec 20167:00 amRNSDirectorate Change
13th Dec 20164:20 pmRNS2016 EGM Results, TVR and Director Dealing
13th Dec 20167:00 amRNSResults of Placing and Open Offer
24th Nov 20165:25 pmRNSPublication of a Prospectus
24th Nov 20167:01 amRNSProposed Acquisition and Placing
22nd Nov 20167:10 amRNSStatement regarding market speculation
22nd Nov 20167:00 amRNSStatement regarding press speculation
26th Oct 20167:00 amRNSDirectorate Change
29th Sep 201610:07 amRNSHolding(s) in Company
31st Aug 20167:00 amRNSHalf-year Report
30th Aug 20167:00 amRNSHolding(s) in Company
10th Aug 201612:17 pmRNSNotice of Results
4th Jul 201610:32 amRNSHolding(s) in Company
14th Jun 20164:30 pmRNSNotification of director share interest
25th May 20161:41 pmRNSHolding(s) in Company
19th May 20167:00 amRNSDirectorate Change
19th May 20167:00 amRNSAppointment of new joint broker
19th May 20167:00 amRNSResult of AGM
28th Apr 20162:32 pmRNSDirector/PDMR Shareholding
20th Apr 20167:00 amRNSAnnual Financial Report 2015 and AGM Notice
31st Mar 20167:00 amRNSFinal Results
24th Mar 20168:45 amRNSNotice of Results
11th Mar 20163:45 pmRNSHolding(s) in Company
3rd Mar 20168:34 amRNSStatement re Legacy Review
30th Nov 20151:56 pmRNSHolding(s) in Company
19th Nov 20157:00 amRNSInterim Management Statement
13th Oct 20156:17 pmRNSHolding(s) in Company
28th Aug 20157:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.